PT1309672E - Processo de producao de reovirus infeccioso - Google Patents

Processo de producao de reovirus infeccioso

Info

Publication number: PT1309672E
Authority: PT; Portugal
Prior art keywords: production process; infectious reovirus; reovirus production; infectious; reovirus
Prior art date: 2000-08-10

Application number

PT01953084T

Other languages

English (en)

Inventor

Matthew C Coffey

Bradley G Thompson

Original Assignee

Oncolytics Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-07-20

Publication date

2005-09-30

2001-07-20 Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc

2005-09-30 Publication of PT1309672E publication Critical patent/PT1309672E/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PT01953084T 2000-08-10 2001-07-20 Processo de producao de reovirus infeccioso PT1309672E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22402600P	2000-08-10	2000-08-10

Publications (1)

Publication Number	Publication Date
PT1309672E true PT1309672E (pt)	2005-09-30

Family

ID=22838987

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT05009952T PT1586634E (pt)	2000-08-10	2001-07-20	Método de produzir reovírus infecciosos
PT01953084T PT1309672E (pt)	2000-08-10	2001-07-20	Processo de producao de reovirus infeccioso

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT05009952T PT1586634E (pt)	2000-08-10	2001-07-20	Método de produzir reovírus infecciosos

Country Status (19)

Country	Link
US (4)	US6528305B2 (pt)
EP (2)	EP1586634B1 (pt)
JP (2)	JP4009532B2 (pt)
AR (1)	AR033993A1 (pt)
AT (2)	ATE394475T1 (pt)
AU (2)	AU7562801A (pt)
BR (1)	BR0113122A (pt)
CA (1)	CA2415749C (pt)
DE (2)	DE60133947D1 (pt)
DK (2)	DK1309672T3 (pt)
ES (2)	ES2241844T3 (pt)
HK (1)	HK1082765A1 (pt)
IL (2)	IL153847A0 (pt)
MX (1)	MXPA03000846A (pt)
NZ (1)	NZ523510A (pt)
PT (2)	PT1586634E (pt)
TW (1)	TWI289158B (pt)
WO (1)	WO2002012435A1 (pt)
ZA (1)	ZA200300410B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545492B1 (en) *	1999-09-20	2003-04-08	Europaisches Laboratorium Fur Molekularbiologie (Embl)	Multiple local probe measuring device and method
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus
BR0207527A (pt) *	2001-03-16	2004-02-25	Oncolytics Biotech Inc	Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
US20040115170A1 (en) *	2001-11-30	2004-06-17	Brown Earl Garnet	Oncolytic virus
US20040005546A1 (en)	2002-02-28	2004-01-08	Oncolytics Biotech Inc.	Use of ribozymes in the detection of adventitious agents
CA2374388C (en)	2002-02-28	2005-07-12	Matthew C. Coffey	The use of ribozymes in the detection of adventitious agents
CA2426283C (en) *	2002-04-29	2006-06-27	The Trustees Of The University Of Pennsylvania	Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
AU2003229159B2 (en)	2002-04-30	2008-02-21	Oncolytics Biotech Inc.	Improved viral purification methods
JP5241059B2 (ja) *	2002-05-09	2013-07-17	オンコリティクスバイオテク，インコーポレーテッド	腫瘍崩壊ウイルスを使用して疼痛を軽減するための方法
EP1944035A1 (en)	2002-05-09	2008-07-16	Oncolytics Biotech Inc.	Method for reducing pain using oncolytic viruses
WO2003094939A1 (en) *	2002-05-10	2003-11-20	Oncolytics Biotech Inc.	Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
US7901921B2 (en)	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
US7490608B2 (en) *	2005-06-17	2009-02-17	Nellcorr Puritan Bennett Llc	System and method for adjusting a gas delivery mask
WO2007099401A2 (en)	2005-08-01	2007-09-07	University Technologies International, Inc.	Oncolytic attenuated reoviruses for treatment of proliferative disorders
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
AU2007215328A1 (en) *	2006-02-13	2007-08-23	Oncolytics Biotech Inc.	Use of local immune suppression to enhance oncolytic viral therapy
US8293498B2 (en)	2006-12-20	2012-10-23	Vanderbilt University	System for generation of viable reovirus from cloned cDNA
US20100322951A1 (en) *	2006-12-29	2010-12-23	Bacilligen, Inc.	Replication-proficient dsRNA capsids and uses thereof
MX2009009598A (es) *	2007-03-12	2009-09-21	Oncolytics Biotech Inc	Reovirus que tienen secuencias modificadas.
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
AR066649A1 (es) *	2007-05-21	2009-09-02	Oncolytics Biotech Inc	Reovirus mutantes y metodos de elaboracion y uso de los mismos
JP2011500608A (ja) *	2007-10-22	2011-01-06	オンコリティクスバイオテク，インコーポレーテッド	増殖性障害の治療レジメン
JP2011520994A (ja) *	2008-05-27	2011-07-21	オンコリティクスバイオテク，インコーポレーテッド	腫瘍崩解性レオウイルス療法中の炎症性サイトカイン産生の排除
TW200951143A (en) *	2008-05-27	2009-12-16	Oncolytics Biotech Inc	Modulating interstitial pressure and oncolytic viral delivery and distribution
US9249195B2 (en)	2010-04-07	2016-02-02	Vanderbilt University	Reovirus vaccines and methods of use therefor
JP2013523175A (ja)	2010-04-14	2013-06-17	イーエムディー・ミリポア・コーポレーション	高力価、高純度のウイルスストックの作製方法及びその使用方法
WO2012075379A2 (en)	2010-12-02	2012-06-07	Oncolytics Biotech Inc.	Liquid viral formulations
AU2011336410B2 (en)	2010-12-02	2015-01-22	Oncolytics Biotech Inc.	Lyophilized viral formulations
CA2930629A1 (en)	2013-11-15	2015-05-21	Oncolytics Biotech Inc.	Oncolytic viruses and increased cancer treatment regimens

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4070453A (en) *	1976-06-25	1978-01-24	Syntex (U.S.A.) Inc.	Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
US4559229A (en) *	1982-07-20	1985-12-17	Research Foundation	Avian proventriculitis vaccine
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja)	1986-08-11	1988-02-25	Biseibutsu Kagaku Kenkyusho:Kk	豚のレオウイルス感染症ワクチン
US5658779A (en)	1992-03-20	1997-08-19	Ligochem, Inc.	Method of adsorbing viruses from fluid compositions
JPH08214876A (ja)	1995-02-15	1996-08-27	Chemo Sero Therapeut Res Inst	ウイルスの調製法
KR100503701B1 (ko)	1996-11-20	2005-07-26	인트로겐 테라페티스, 인코퍼레이티드	아데노바이러스 벡터를 생산하고 정제하는 개선된 방법
EP0993443A1 (de)	1997-06-24	2000-04-19	Basf Aktiengesellschaft	Verfahren zur herstellung von 4,4'-dihalogendiphenylsulfon
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
US6136307A (en)	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
AR028039A1 (es)	2000-05-03	2003-04-23	Oncolytics Biotech Inc	Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus

2001
- 2001-07-19 TW TW90117712A patent/TWI289158B/zh not_active IP Right Cessation
- 2001-07-20 IL IL15384701A patent/IL153847A0/xx active IP Right Grant
- 2001-07-20 PT PT05009952T patent/PT1586634E/pt unknown
- 2001-07-20 JP JP2002517726A patent/JP4009532B2/ja not_active Expired - Lifetime
- 2001-07-20 AT AT05009952T patent/ATE394475T1/de not_active IP Right Cessation
- 2001-07-20 ES ES01953084T patent/ES2241844T3/es not_active Expired - Lifetime
- 2001-07-20 DK DK01953084T patent/DK1309672T3/da active
- 2001-07-20 BR BR0113122A patent/BR0113122A/pt not_active IP Right Cessation
- 2001-07-20 EP EP20050009952 patent/EP1586634B1/en not_active Expired - Lifetime
- 2001-07-20 WO PCT/CA2001/001054 patent/WO2002012435A1/en active IP Right Grant
- 2001-07-20 DE DE60133947T patent/DE60133947D1/de not_active Expired - Lifetime
- 2001-07-20 CA CA 2415749 patent/CA2415749C/en not_active Expired - Lifetime
- 2001-07-20 MX MXPA03000846A patent/MXPA03000846A/es active IP Right Grant
- 2001-07-20 PT PT01953084T patent/PT1309672E/pt unknown
- 2001-07-20 ES ES05009952T patent/ES2305940T3/es not_active Expired - Lifetime
- 2001-07-20 NZ NZ523510A patent/NZ523510A/en unknown
- 2001-07-20 AU AU7562801A patent/AU7562801A/xx active Pending
- 2001-07-20 ZA ZA200300410A patent/ZA200300410B/xx unknown
- 2001-07-20 AU AU2001275628A patent/AU2001275628B2/en not_active Expired
- 2001-07-20 DE DE2001611747 patent/DE60111747T2/de not_active Expired - Lifetime
- 2001-07-20 AT AT01953084T patent/ATE298788T1/de not_active IP Right Cessation
- 2001-07-20 DK DK05009952T patent/DK1586634T3/da active
- 2001-07-20 EP EP01953084A patent/EP1309672B1/en not_active Expired - Lifetime
- 2001-08-02 US US09/920,012 patent/US6528305B2/en not_active Expired - Lifetime
- 2001-08-03 AR ARP010103738 patent/AR033993A1/es active IP Right Grant
2003
- 2003-01-08 IL IL153847A patent/IL153847A/en unknown
- 2003-01-08 US US10/337,911 patent/US6703232B2/en not_active Expired - Lifetime
- 2003-12-11 US US10/734,552 patent/US7049127B2/en not_active Expired - Lifetime
2006
- 2006-03-27 US US11/390,885 patent/US7429485B2/en not_active Expired - Lifetime
- 2006-04-03 HK HK06104055A patent/HK1082765A1/xx not_active IP Right Cessation
- 2006-08-30 JP JP2006234596A patent/JP2006314336A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
AU7562801A (en)	2002-02-18
IL153847A (en)	2007-10-31
US20020037576A1 (en)	2002-03-28
IL153847A0 (en)	2003-07-31
US6703232B2 (en)	2004-03-09
EP1309672B1 (en)	2005-06-29
ES2241844T3 (es)	2005-11-01
ZA200300410B (en)	2004-01-26
US20040126869A1 (en)	2004-07-01
BR0113122A (pt)	2003-07-22
JP2006314336A (ja)	2006-11-24
JP2004505623A (ja)	2004-02-26
ATE394475T1 (de)	2008-05-15
CA2415749C (en)	2009-05-12
HK1082765A1 (en)	2006-06-16
AR033993A1 (es)	2004-01-21
ES2305940T3 (es)	2008-11-01
JP4009532B2 (ja)	2007-11-14
PT1586634E (pt)	2008-06-19
WO2002012435A1 (en)	2002-02-14
DE60133947D1 (de)	2008-06-19
NZ523510A (en)	2004-08-27
TWI289158B (en)	2007-11-01
ATE298788T1 (de)	2005-07-15
MXPA03000846A (es)	2004-04-05
US20060165724A1 (en)	2006-07-27
US20030166253A1 (en)	2003-09-04
CA2415749A1 (en)	2002-02-14
EP1586634B1 (en)	2008-05-07
AU2001275628B8 (en)	2002-02-18
US6528305B2 (en)	2003-03-04
US7049127B2 (en)	2006-05-23
DK1586634T3 (da)	2008-08-18
AU2001275628B2 (en)	2007-08-30
DE60111747T2 (de)	2006-04-27
DE60111747D1 (de)	2005-08-04
EP1309672A1 (en)	2003-05-14
DK1309672T3 (da)	2005-10-10
EP1586634A1 (en)	2005-10-19
US7429485B2 (en)	2008-09-30

Publication	Publication Date	Title
PT1309672E (pt)	2005-09-30	Processo de producao de reovirus infeccioso
PT1345936E (pt)	2004-09-30	Processo para a producao do anticolinergico brometo de tiotropio
ATE376005T1 (de)	2007-11-15	Polymerisationsverfahren
DE60205413D1 (de)	2005-09-15	Herstellungsverfahren
BR0112759B1 (pt)	2013-10-29	Processo de recuperação de cobre
NO20010146D0 (no)	2001-01-09	Fremgangsmåte for ökning av hydrokarbonproduksjon
DE60106503D1 (de)	2004-11-25	Luftreifen
DE60216133D1 (de)	2006-12-28	Reifenherstellungsverfahren
DE50209888D1 (de)	2007-05-24	Druckverfahren
AR028002A1 (es)	2003-04-23	Metodos para la produccion de ansamitocina
DE10196082T1 (de)	2003-03-13	FLIP-CHIP-Montageverfahren
DE60130046D1 (de)	2007-09-27	Knotenauswahlverfahren
BR0210053B1 (pt)	2011-05-31	processo de fabricação de nylon-6.
PT1326836E (pt)	2004-07-30	Processo de producao de 3-amido-2-cloro-4-metilpiridina
DE60113311D1 (de)	2005-10-20	Luftreifen
ATE373485T1 (de)	2007-10-15	Herstellungsverfahren für kombinationsimpfstoffe
DE60130137D1 (de)	2007-10-04	Kristallisationsverfahren
IS6716A (is)	2003-02-13	Aðferðir við að framleiða sílostasól
DE60130426D1 (de)	2007-10-25	Aluminiumoxid-Leuchtstoff- Herstellungsverfahren
DE60103432D1 (de)	2004-07-01	Luftreifen
PT1401846E (pt)	2005-04-29	Processo para a obtencao de n-fosfonometilglicina
BR0105722B1 (pt)	2010-08-24	processo para evitar a formaÇço de incrustaÇço.
PT1127876E (pt)	2003-03-31	Processo de preparacao de isoindolina
NO20023714L (no)	2002-10-03	Ny koblingsprosess
DE60135923D1 (de)	2008-11-06	Nitril-verfahren